Data / Drug companies / Prochlorperazine edisylate
Prochlorperazine edisylate: 16 companies and 18 products in the FDA NDC directory
Prochlorperazine edisylate is listed in the FDA National Drug Code Directory by 16 companies, with 18 products in commercial distribution. 18 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection; injection, solution, and the newest product started marketing on April 8, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 16
- Products
- 18
- Generic (ANDA) products
- 18 (100.0%)
- Application numbers
- 9
- Routes
- Intramuscular, Intravenous
- openFDA record search
- api.fda.gov
Companies that list prochlorperazine edisylate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Gland Pharma Limited | 2 | injection | Generic drugs (ANDA) | September 22, 2021 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | injection | Generic drugs (ANDA) | June 26, 2015 |
| Amneal Pharmaceuticals LLC | 1 | injection | Generic drugs (ANDA) | December 12, 2022 |
| Avenacy, LLC | 1 | injection, solution | Generic drugs (ANDA) | June 1, 2024 |
| Baxter Healthcare Corporation | 1 | injection | Generic drugs (ANDA) | May 3, 2021 |
| Caplin Steriles Limited | 1 | injection | Generic drugs (ANDA) | April 8, 2026 |
| Cardinal Health 107, LLC | 1 | injection | Generic drugs (ANDA) | March 26, 2012 |
| Civica, Inc. | 1 | injection | Generic drugs (ANDA) | November 18, 2019 |
| Cosette Pharmaceuticals, Inc. | 1 | injection | Generic drugs (ANDA) | February 11, 2022 |
| Eugia US LLC | 1 | injection | Generic drugs (ANDA) | July 14, 2022 |
| Fosun Pharma USA Inc. | 1 | injection | Generic drugs (ANDA) | May 1, 2023 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | injection | Generic drugs (ANDA) | June 15, 2022 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection | Generic drugs (ANDA) | August 29, 1989 |
| Mylan Institutional LLC | 1 | injection | Generic drugs (ANDA) | April 3, 2019 |
| Sagent Pharmaceuticals | 1 | injection | Generic drugs (ANDA) | November 15, 2021 |
| Somerset Therapeutics, LLC | 1 | injection | Generic drugs (ANDA) | October 10, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 17 | 94.4% |
| Injection, solution | 1 | 5.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 18 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Phenothiazine | 18 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.